The sponsor should utilize qualified individuals throughout all stages of the trial for which purpose?

• A. Only Patient Recruitment
• B. Protocol Design, CRFs, Planning Analyses, and Reporting
• C. Only Data Collection
• D. Only Statistical Analysis

Answer: (B)

Qualified individuals across the entire trial lifecycle are essential to protect participants and ensure credible results. In protocol design, experts ensure the study question, endpoints, inclusion criteria, safety monitoring, and ethical safeguards are sound and scientifically appropriate. In developing the case report forms, they ensure the data collected are relevant, clearly defined, and captured consistently, which minimizes missing data and measurement error. In planning analyses, biostatisticians pre-specify statistical methods, handling of missing data, and sample size considerations to avoid bias and data-driven conclusions. In reporting, qualified writers and analysts ensure results are communicated accurately and transparently, with proper interpretation of safety signals and regulatory requirements. Therefore, involving qualified individuals in these stages—protocol design, CRFs, planning analyses, and reporting—best supports the trial’s scientific validity and regulatory compliance. Focusing only on recruitment, data collection, or analysis neglects other critical aspects and can undermine quality and compliance.